These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 19358225)

  • 1. Quantitative signal detection using spontaneous ADR reporting.
    Bate A; Evans SJ
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):427-36. PubMed ID: 19358225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reporting odds ratio and its advantages over the proportional reporting ratio.
    Rothman KJ; Lanes S; Sacks ST
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):519-23. PubMed ID: 15317031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China.
    Li C; Xia J; Deng J; Jiang J
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):593-600. PubMed ID: 18432629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of data mining methodologies using Japanese spontaneous reports.
    Kubota K; Koide D; Hirai T
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):387-94. PubMed ID: 15170768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computerized system for signal detection in spontaneous reporting system of Shanghai China.
    Ye X; Fu Z; Wang H; Du W; Wang R; Sun Y; Gao Q; He J
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):154-8. PubMed ID: 19115240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data mining in spontaneous reports.
    Bate A; Edwards IR
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):324-30. PubMed ID: 16611210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.
    van Puijenbroek EP; Bate A; Leufkens HG; Lindquist M; Orre R; Egberts AC
    Pharmacoepidemiol Drug Saf; 2002; 11(1):3-10. PubMed ID: 11998548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
    Moore N; Thiessard F; Begaud B
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):285-6. PubMed ID: 15782397
    [No Abstract]   [Full Text] [Related]  

  • 9. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China.
    Hou Y; Ye X; Wu G; Cheng G; Du X; He J
    Expert Opin Drug Saf; 2014 Jul; 13(7):853-7. PubMed ID: 24918197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data mining for signals in spontaneous reporting databases: proceed with caution.
    Stephenson WP; Hauben M
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):359-65. PubMed ID: 17019675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal detection of methylphenidate by comparing a spontaneous reporting database with a claims database.
    Kim J; Kim M; Ha JH; Jang J; Hwang M; Lee BK; Chung MW; Yoo TM; Kim MJ
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):154-60. PubMed ID: 21510997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing data mining methods on the VAERS database.
    Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential competition bias in the detection of safety signals from spontaneous reporting databases.
    Pariente A; Didailler M; Avillach P; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Moore N
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1166-71. PubMed ID: 20848561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of data mining in pharmacovigilance.
    Hauben M; Madigan D; Gerrits CM; Walsh L; Van Puijenbroek EP
    Expert Opin Drug Saf; 2005 Sep; 4(5):929-48. PubMed ID: 16111454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China.
    Wang J; Ye XF; Guo XJ; Zhu TT; Qi N; Hou YF; Zhang TY; Shi WT; Wei X; Liu YZ; Wu GZ; He J
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):962-70. PubMed ID: 26095121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.
    Bate A; Lindquist M; Orre R; Edwards IR; Meyboom RH
    Eur J Clin Pharmacol; 2002 Oct; 58(7):483-90. PubMed ID: 12389072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
    Hauben M; Reich L; Gerrits CM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A shrinkage-based comparative assessment of observed-to-expected disproportionality measures.
    Gipson G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):589-96. PubMed ID: 22290739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.